Multifunctional Roles of Activins in the Brain

Vitamins and Hormones

Volumn 85, Issue , 2011, Pages 185-206

  Ageta, Hiroshi ^a   Tsuchida, Kunihiro ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Depression; Follistatin; Late phase LTP; Long term memory; Neurogenesis; Spine formation

Indexed keywords

ACTIVIN;

ANIMAL; ANXIETY; BOOK; BRAIN; HUMAN; MEMORY; METABOLISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PHYSIOLOGY;

ACTIVINS; ANIMALS; ANXIETY; BRAIN; HUMANS; MEMORY; NEUROGENESIS; NEURONS;

EID: 79951880175     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385961-7.00009-3     Document Type: Book

References (96)

1. Abdipranoto-Cowley A., Park J.S., Croucher D., Daniel J., Henshall S., Galbraith S., Mervin K., Vissel B. Activin A is essential for neurogenesis following neurodegeneration. Stem Cells 2009, 27:1330-1346.
2. Abraham W.C., Mason S.E., Demmer J., Williams J.M., Richardson C.L., Tate W.P., Lawlor P.A., Dragunow M. Correlations between immediate early gene induction and the persistence of long-term potentiation. Neuroscience 1993, 56:717-727.
3. Ageta H., Kato A., Fukazawa Y., Inokuchi K., Sugiyama H. Effects of proteasome inhibitors on the synaptic localization of Vesl-1S/Homer-1a proteins. Brain Res. Mol. Brain Res. 2001, 97:186-189.
4. Ageta H., Kato A., Hatakeyama S., Nakayama K., Isojima Y., Sugiyama H. Regulation of the level of Vesl-1S/Homer-1a proteins by ubiquitin-proteasome proteolytic systems. J. Biol. Chem. 2001, 276:15893-15897.
5. Ageta H., Murayama A., Migishima R., Kida S., Tsuchida K., Yokoyama M., Inokuchi K. Activin in the brain modulates anxiety-related behavior and adult neurogenesis. PLoS ONE 2008, 3:e1869.
6. Ageta H., Ikegami S., Miura M., Masuda M., Migishima R., Hino T., Takashima N., Murayama A., Sugino H., Setou M., Kida S., Yokoyama M., et al. Activin plays a key role in the maintenance of long-term memory and late-LTP. Learn. Mem. 2010, 17:168-175.
7. Andreasson K., Worley P.F. Induction of beta-A activin expression by synaptic activity and during neocortical development. Neuroscience 1995, 69:781-796.
8. Anokhin K.V., Tiunova A.A., Rose S.P. Reminder effects - reconsolidation or retrieval deficit? Pharmacological dissection with protein synthesis inhibitors following reminder for a passive-avoidance task in young chicks. Eur. J. Neurosci. 2002, 15:1759-1765.
9. Bao Y.L., Tsuchida K., Liu B., Kurisaki A., Matsuzaki T., Sugino H. Synergistic activity of activin A and basic fibroblast growth factor on tyrosine hydroxylase expression through Smad3 and ERK1/ERK2 MAPK signaling pathways. J. Endocrinol. 2005, 184:493-504.
10. Bourtchuladze R., Frenguelli B., Blendy J., Cioffi D., Schutz G., Silva A.J. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994, 79:59-68.
11. Bozon B., Davis S., Laroche S. A requirement for the immediate early gene zif268 in reconsolidation of recognition memory after retrieval. Neuron 2003, 40:695-701.
12. Brakeman P.R., Lanahan A.A., O'Brien R., Roche K., Barnes C.A., Huganir R.L., Worley P.F. Homer: A protein that selectively binds metabotropic glutamate receptors. Nature 1997, 386:284-288.
13. Cameron V.A., Nishimura E., Mathews L.S., Lewis K.A., Sawchenko P.E., Vale W.W. Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology 1994, 134:799-808.
14. Castellucci V.F., Blumenfeld H., Goelet P., Kandel E.R. Inhibitor of protein synthesis blocks long-term behavioral sensitization in the isolated gill-withdrawal reflex of Aplysia. J. Neurobiol. 1989, 20:1-9.
15. Cole A.J., Saffen D.W., Baraban J.M., Worley P.F. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 1989, 340:474-476.
16. de Guise C., Lacerte A., Rafiei S., Reynaud R., Roy M., Brue T., Lebrun J.J. Activin inhibits the human Pit-1 gene promoter through the p38 kinase pathway in a Smad-independent manner. Endocrinology 2006, 147:4351-4362.
17. Di Guglielmo G.M., Le Roy C., Goodfellow A.F., Wrana J.L. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat. Cell Biol. 2003, 5:410-421.
18. Dow A.L., Russell D.S., Duman R.S. Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: Effects in behavioral models. J. Neurosci. 2005, 25:4908-4916.
19. Ebisawa T., Fukuchi M., Murakami G., Chiba T., Tanaka K., Imamura T., Miyazono K. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 2001, 276:12477-12480.
20. Eisenberg M., Kobilo T., Berman D.E., Dudai Y. Stability of retrieved memory: Inverse correlation with trace dominance. Science 2003, 301:1102-1104.
21. Fischer M., Kaech S., Knutti D., Matus A. Rapid actin-based plasticity in dendritic spines. Neuron 1998, 20:847-854.
22. Fischer M., Kaech S., Wagner U., Brinkhaus H., Matus A. Glutamate receptors regulate actin-based plasticity in dendritic spines. Nat. Neurosci. 2000, 3:887-894.
23. Frey U., Krug M., Reymann K.G., Matthies H. Anisomycin, an inhibitor of protein synthesis, blocks late phases of LTP phenomena in the hippocampal CA1 region in vitro. Brain Res. 1988, 452:57-65.
24. Fukazawa Y., Saitoh Y., Ozawa F., Ohta Y., Mizuno K., Inokuchi K. Hippocampal LTP is accompanied by enhanced F-actin content within the dendritic spine that is essential for late LTP maintenance in vivo. Neuron 2003, 38:447-460.
25. Fukushima T., Liu R.Y., Byrne J.H. Transforming growth factor-beta2 modulates synaptic efficacy and plasticity and induces phosphorylation of CREB in hippocampal neurons. Hippocampus 2007, 17:5-9.
26. Funaba M., Murata T., Fujimura H., Murata E., Abe M., Torii K. Immunolocalization of type I or type II activin receptors in the rat brain. J. Neuroendocrinol. 1997, 9:105-111.
27. Gage F.H. Neurogenesis in the adult brain. J. Neurosci. 2002, 22:612-613.
28. Gamer L.W., Wolfman N.M., Celeste A.J., Hattersley G., Hewick R., Rosen V. A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev. Biol. 1999, 208:222-232.
29. Gellibert F., de Gouville A.C., Woolven J., Mathews N., Nguyen V.L., Bertho-Ruault C., Patikis A., Grygielko E.T., Laping N.J., Huet S. Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): A potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor. J. Med. Chem. 2006, 49:2210-2221.
30. Hata Y., Takai Y. Roles of postsynaptic density-95/synapse-associated protein 90 and its interacting proteins in the organization of synapses. Cell. Mol. Life Sci. 1999, 56:461-472.
31. Hennou S., Kato A., Schneider E.M., Lundstrom K., Gahwiler B.H., Inokuchi K., Gerber U., Ehrengruber M.U. Homer-1a/Vesl-1S enhances hippocampal synaptic transmission. Eur. J. Neurosci. 2003, 18:811-819.
32. Honkura N., Matsuzaki M., Noguchi J., Ellis-Davies G.C., Kasai H. The subspine organization of actin fibers regulates the structure and plasticity of dendritic spines. Neuron 2008, 57:719-729.
33. Hughes P.E., Alexi T., Williams C.E., Clark R.G., Gluckman P.D. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 1999, 92:197-209.
34. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 2002, 62:65-74.
35. Inokuchi K., Kato A., Hiraia K., Hishinuma F., Inoue M., Ozawa F. Increase in activin beta A mRNA in rat hippocampus during long-term potentiation. FEBS Lett. 1996, 382:48-52.
36. Inoue N., Nakao H., Migishima R., Hino T., Matsui M., Hayashi F., Nakao K., Manabe T., Aiba A., Inokuchi K. Requirement of the immediate early gene vesl-1S/homer-1a for fear memory formation. Mol. Brain 2009, 2:7.
37. Jones M.W., Errington M.L., French P.J., Fine A., Bliss T.V., Garel S., Charnay P., Bozon B., Laroche S., Davis S. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat. Neurosci. 2001, 4:289-296.
38. Kato A., Ozawa F., Saitoh Y., Hirai K., Inokuchi K. vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis. FEBS Lett. 1997, 412:183-189.
39. Kato A., Ozawa F., Saitoh Y., Fukazawa Y., Sugiyama H., Inokuchi K. Novel members of the Vesl/Homer family of PDZ proteins that bind metabotropic glutamate receptors. J. Biol. Chem. 1998, 273:23969-23975.
40. Kelly A., Laroche S., Davis S. Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase in hippocampal circuitry is required for consolidation and reconsolidation of recognition memory. J. Neurosci. 2003, 23:5354-5360.
41. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51:8-19.
42. Kitamura T., Saitoh Y., Takashima N., Murayama A., Niibori Y., Ageta H., Sekiguchi M., Sugiyama H., Inokuchi K. Adult neurogenesis modulates the hippocampus-dependent period of associative fear memory. Cell 2009, 139:814-827.
43. Kokaia Z., Lindvall O. Neurogenesis after ischaemic brain insults. Curr. Opin. Neurobiol. 2003, 13:127-132.
44. Kuhn H.G., Dickinson-Anson H., Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J. Neurosci. 1996, 16:2027-2033.
45. Kurisaki A., Inoue I., Kurisaki K., Yamakawa N., Tsuchida K., Sugino H. Activin induces long-lasting N-methyl-D-aspartate receptor activation via scaffolding PDZ protein activin receptor interacting protein 1. Neuroscience 2008, 151:1225-1235.
46. Ling N., Ying S.Y., Ueno N., Shimasaki S., Esch F., Hotta M., Guillemin R. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986, 321:779-782.
47. Lyford G.L., Yamagata K., Kaufmann W.E., Barnes C.A., Sanders L.K., Copeland N.G., Gilbert D.J., Jenkins N.A., Lanahan A.A., Worley P.F. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 1995, 14:433-445.
48. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
49. Mather J.P., Moore A., Li R.H. Activins, inhibins, and follistatins: Further thoughts on a growing family of regulators. Proc. Soc. Exp. Biol. Med. 1997, 215:209-222.
50. Matus A. Growth of dendritic spines: A continuing story. Curr. Opin. Neurobiol. 2005, 15:67-72.
51. Matzuk M.M., Kumar T.R., Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 1995, 374:356-360.
52. Matzuk M.M., Kumar T.R., Vassalli A., Bickenbach J.R., Roop D.R., Jaenisch R., Bradley A. Functional analysis of activins during mammalian development. Nature 1995, 374:354-356.
53. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
54. Muir K.W. Glutamate-based therapeutic approaches: Clinical trials with NMDA antagonists. Curr. Opin. Pharmacol. 2006, 6:53-60.
55. Mukherjee S., Sackeim H.A., Schnur D.B. Electroconvulsive therapy of acute manic episodes: A review of 50 years' experience. Am. J. Psychiatry 1994, 151:169-176.
56. Nader K. Memory traces unbound. Trends Neurosci. 2003, 26:65-72.
57. Nader K., Schafe G.E., Le Doux J.E. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 2000, 406:722-726.
58. Nakamura T., Asashima M., Eto Y., Takio K., Uchiyama H., Moriya N., Ariizumi T., Yashiro T., Sugino K., Titani K., et al. Isolation and characterization of native activin B. J. Biol. Chem. 1992, 267:16385-16389.
59. Nakashima M., Toyono T., Akamine A., Joyner A. Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis. Mech. Dev. 1999, 80:185-189.
60. Nguyen P.V., Abel T., Kandel E.R. Requirement of a critical period of transcription for induction of a late phase of LTP. Science 1994, 265:1104-1107.
61. Pangas S.A., Woodruff T.K. Activin signal transduction pathways. Trends Endocrinol. Metab. 2000, 11:309-314.
62. Parsons C.G., Danysz W., Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist-A review of preclinical data. Neuropharmacology 1999, 38:735-767.
63. Pedreira M.E., Perez-Cuesta L.M., Maldonado H. Reactivation and reconsolidation of long-term memory in the crab Chasmagnathus: Protein synthesis requirement and mediation by NMDA-type glutamatergic receptors. J. Neurosci. 2002, 22:8305-8311.
64. Plath N., Ohana O., Dammermann B., Errington M.L., Schmitz D., Gross C., Mao X., Engelsberg A., Mahlke C., Welzl H., Kobalz U., Stawrakakis A., et al. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 2004, 52:437-444.
65. Sala C., Futai K., Yamamoto K., Worley P.F., Hayashi Y., Sheng M. Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a. J. Neurosci. 2003, 23:6327-6337.
66. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
67. Sawa A., Snyder S.H. Schizophrenia: Diverse approaches to a complex disease. Science 2002, 296:692-695.
68. Sekiguchi M., Hayashi F., Tsuchida K., Inokuchi K. Neuron type-selective effects of activin on development of the hippocampus. Neurosci. Lett. 2009, 452:232-237.
69. Sharma M., Kambadur R., Matthews K.G., Somers W.G., Devlin G.P., Conaglen J.V., Fowke P.J., Bass J.J. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J. Cell. Physiol. 1999, 180:1-9.
70. Sheng M., Sala C. PDZ domains and the organization of supramolecular complexes. Annu. Rev. Neurosci. 2001, 24:1-29.
71. Shoji H., Tsuchida K., Kishi H., Yamakawa N., Matsuzaki T., Liu Z., Nakamura T., Sugino H. Identification and characterization of a PDZ protein that interacts with activin type II receptors. J. Biol. Chem. 2000, 275:5485-5492.
72. Shoji-Kasai Y., Ageta H., Hasegawa Y., Tsuchida K., Sugino H., Inokuchi K. Activin increases the number of synaptic contacts and the length of dendritic spine necks by modulating spinal actin dynamics. J. Cell Sci. 2007, 120:3830-3837.
73. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001, 410:372-376.
74. Skolnick P. Antidepressants for the new millennium. Eur. J. Pharmacol. 1999, 375:31-40.
75. Squire L.R., Barondes S.H. Memory impairment during prolonged training in mice given inhibitors of cerebral protein synthesis. Brain Res. 1973, 56:215-225.
76. Suzuki A., Josselyn S.A., Frankland P.W., Masushige S., Silva A.J., Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J. Neurosci. 2004, 24:4787-4795.
77. Talmage D.A. Mechanisms of neuregulin action. Novartis Found. Symp. 2008, 289:74-84. discussion 84-93.
78. ten Dijke P., Hill C.S. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 2004, 29:265-273.
79. ten Dijke P., Miyazono K., Heldin C.H. Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem. Sci. 2000, 25:64-70.
80. Tretter Y.P., Hertel M., Munz B., ten Bruggencate G., Werner S., Alzheimer C. Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat. Med. 2000, 6:812-815.
81. Tronson N.C., Taylor J.R. Molecular mechanisms of memory reconsolidation. Nat. Rev. Neurosci. 2007, 8:262-275.
82. Tsuchida K. Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2004, 4:157-166.
83. Tsuchida K., Nakatani M., Hitachi K., Uezumi A., Sunada Y., Ageta H., Inokuchi K. Activin signaling as an emerging target for therapeutic interventions. Cell Commun. Signal 2009, 7:15.
84. Tu J.C., Xiao B., Naisbitt S., Yuan J.P., Petralia R.S., Brakeman P., Doan A., Aakalu V.K., Lanahan A.A., Sheng M., Worley P.F. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 1999, 23:583-592.
85. Vale W., Rivier J., Vaughan J., McClintock R., Corrigan A., Woo W., Karr D., Spiess J. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986, 321:776-779.
86. Walker M.P., Brakefield T., Hobson J.A., Stickgold R. Dissociable stages of human memory consolidation and reconsolidation. Nature 2003, 425:616-620.
87. Wang R., Dineley K.T., Sweatt J.D., Zheng H. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience 2004, 126:305-312.
88. Werner S., Alzheimer C. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev. 2006, 17:157-171.
89. Wong M.L., Licinio J. From monoamines to genomic targets: A paradigm shift for drug discovery in depression. Nat. Rev. Drug Discov. 2004, 3:136-151.
90. Wu D.D., Lai M., Hughes P.E., Sirimanne E., Gluckman P.D., Williams C.E. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res. 1999, 835:369-378.
91. Wu H.H., Ivkovic S., Murray R.C., Jaramillo S., Lyons K.M., Johnson J.E., Calof A.L. Autoregulation of neurogenesis by GDF11. Neuron 2003, 37:197-207.
92. Yamaguchi T., Kurisaki A., Yamakawa N., Minakuchi K., Sugino H. FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor. J. Mol. Endocrinol. 2006, 36:569-579.
93. Yao I., Takagi H., Ageta H., Kahyo T., Sato S., Hatanaka K., Fukuda Y., Chiba T., Morone N., Yuasa S., Inokuchi K., Ohtsuka T., et al. SCRAPPER-dependent ubiquitination of active zone protein RIM1 regulates synaptic vesicle release. Cell 2007, 130:943-957.
94. Ying S.Y., Zhang Z., Furst B., Batres Y., Huang G., Li G. Activins and activin receptors in cell growth. Proc. Soc. Exp. Biol. Med. 1997, 214:114-122.
95. Zhang F., Endo S., Cleary L.J., Eskin A., Byrne J.H. Role of transforming growth factor-beta in long-term synaptic facilitation in Aplysia. Science 1997, 275:1318-1320.
96. Zheng F., Adelsberger H., Muller M.R., Fritschy J.M., Werner S., Alzheimer C. Activin tunes GABAergic neurotransmission and modulates anxiety-like behavior. Mol. Psychiatry 2009, 14:332-346.